Octinoxate, Titanium Dioxide Emulsion
NDC Package 64141-902-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Octinoxate, Titanium Dioxide emulsions is a drug for further processing. This formulation utilizes a emulsion delivery system. Marketed by Bobbi Brown Professional Cosmetics Inc., this product is identified by NDC 64141-902.

Identification & Billing

NDC Package Code
64141-902-05
Package Description
10 kg in 1 PAIL
Product Code
11-Digit Billing Format
64141090205

Clinical Specifications

Proprietary Name
Octinoxate, Titanium Dioxide
Non-Proprietary Name
Octinoxate, Titanium Dioxide
Substance Name
Octinoxate; Titanium Dioxide
Dosage Form
Emulsion - A dosage form consisting of a two-phase system comprised of at least two immiscible liquids1, one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. (Note: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment.)

Regulatory & Marketing

Labeler Name
Bobbi Brown Professional Cosmetics Inc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
12-20-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (64141-902). Click a package code to view its specific billing and regulatory data.

200 kg in 1 DRUM
20 kg in 1 DRUM
5 kg in 1 PAIL
150 kg in 1 DRUM

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64141-902-05 identifies a specific commercial package of 10 kg in 1 pail of Octinoxate, Titanium Dioxide (UNFINISHED drug), drug for further processing labeled by Bobbi Brown Professional Cosmetics Inc.. This emulsion is formulated for use and contains octinoxate; titanium dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bobbi Brown Professional Cosmetics Inc. on December 20, 2024. The current certification is valid through December 31, 2026.

How is this Bobbi Brown Professional Cosmetics Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64141090205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64141-902-05
11-Digit CMS (5-4-2)
64141-0902-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.